The Cancer Care Business Exchange is a high-level, multistakeholder forum that focuses on the business implications of the changing complexities in cancer care delivery and payment.
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the evolving landscape of cancer screening—from the advances in imaging and artificial intelligence to the promise and pitfalls of new DNA- and...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the evolving landscape of cancer screening—from the advances in imaging and artificial intelligence to the promise and pitfalls of new DNA- and...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the many dimensions of second opinions in oncology—ranging from in-practice consultations to academic referrals, payer-sponsored programs, and...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the many dimensions of second opinions in oncology—ranging from in-practice consultations to academic referrals, payer-sponsored programs, and...
Drug prices are the focus of many people in health care, but no one is measuring the total cost of delivering the drugs to the patient. Getting a patient through chemotherapy requires attention to their side effects and toxicities, and their...
Drug prices are the focus of many people in health care, but no one is measuring the total cost of delivering the drugs to the patient. Getting a patient through chemotherapy requires attention to their side effects and toxicities, and their...
Decision support for oncology treatment has been at the forefront of oncology decision-making for over 20 years, yet the methods in which we evaluate and select regimens for a pathway has remained the same. Within our community, we have all...
Decision support for oncology treatment has been at the forefront of oncology decision-making for over 20 years, yet the methods in which we evaluate and select regimens for a pathway has remained the same. Within our community, we have all...
Learn how a thoughtfully integrated combination of clinical teams and scalable, [artificial intelligence] technology can enable around-the-clock patient support, reinforce adherence to evidence-based clinical pathways, and extend high-quality...
Learn how a thoughtfully integrated combination of clinical teams and scalable, [artificial intelligence] technology can enable around-the-clock patient support, reinforce adherence to evidence-based clinical pathways, and extend high-quality...
Artificial intelligence (AI) is not a future concept in oncology—it’s here, integrated into daily workflows and documentation at the point of care. But with that progress comes a new set of questions: Are we implementing AI in a way that...
Artificial intelligence (AI) is not a future concept in oncology—it’s here, integrated into daily workflows and documentation at the point of care. But with that progress comes a new set of questions: Are we implementing AI in a way that...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the undervalued yet critical role of primary care in the health care ecosystem—especially in oncology—highlighting its impact on early detection,...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the undervalued yet critical role of primary care in the health care ecosystem—especially in oncology—highlighting its impact on early detection,...
In this edition of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the limitations of current medical education—from outdated testing and board certification to gaps in real-world practice preparedness—and call for...
In this edition of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the limitations of current medical education—from outdated testing and board certification to gaps in real-world practice preparedness—and call for...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej discuss the evolution of remote patient engagement in oncology—from the rapid expansion of telemedicine during COVID-19 to the growing role of tools like...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej discuss the evolution of remote patient engagement in oncology—from the rapid expansion of telemedicine during COVID-19 to the growing role of tools like...
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...